Mouse Monoclonal DDB2 antibody. Suitable for IHC-P, Flow Cyt, WB, ICC/IF and reacts with Human samples. Cited in 18 publications. Immunogen corresponding to Recombinant Fragment Protein within Human DDB2.
View Alternative Names
DNA damage-binding protein 2, DDB p48 subunit, Damage-specific DNA-binding protein 2, UV-damaged DNA-binding protein 2, DDBb, UV-DDB 2, DDB2
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DDB2 antibody [2246C4a] (AB51017)
IHC image of ab51017 staining in human normal cervical carcinoma formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab51017, 5µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-DDB2 antibody [2246C4a] (AB51017)
ICC/IF image of ab51017 stained HeLa cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab51017, 10µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
- Flow Cyt
Unknown
Flow Cytometry - Anti-DDB2 antibody [2246C4a] (AB51017)
Overlay histogram showing HeLa cells stained with ab51017 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab51017, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells ) used under the same conditions. Acquisition of >5,000 events was performed.
- WB
Unknown
Western blot - Anti-DDB2 antibody [2246C4a] (AB51017)
All lanes:
Western blot - Anti-DDB2 antibody [2246C4a] (ab51017) at 1/50 dilution
All lanes:
HeLa whole cell lysate at 50 µg
Secondary
All lanes:
Mouse IgG antibody at 1/2500 dilution
Predicted band size: 48 kDa
Observed band size: 45 kDa
true
- WB
CiteAb
Western blot - Anti-DDB2 antibody [2246C4a] (AB51017)
DDB2 western blot using anti-DDB2 antibody [2246C4a] ab51017. Publication image and figure legend from Luch, A., Frey, F. C., et al., 2014, PLoS One, PubMed 24722772.
ab51017 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab51017 please see the product overview.
Association of UV-DDB with damaged chromatin.(A) Flow diagram illustrating how chromatin was dissected to monitor the binding of UV-DDB. Unbound proteins were released by salt (0.3 M NaCl) extraction and the remaining chromatin was solubilized by MNase digestion. (B) Western blot visualization of the chromatin partitioning of UV-DDB using antibodies against DDB2. GAPDH (glyceraldehyde 3-phosphate dehydrogenase), marker of unbound proteins; histone H3, marker of chromatin. Human fibroblasts were exposed for 18 h to formaldehyde or UV-irradiated at the indicated doses. (C) Quantification of three independent binding assays demonstrating the differential interaction of DDB2 with formaldehyde- and UV-damaged chromatin (error bars, S.D.). (D) Release of chromatin-bound DDB2 and histone H3 by high-salt extraction. After incubation with 0.3 M NaCl buffer, the chromatin was dissolved with 2.5 M NaCl, thus liberating non-covalently bound chromatin proteins.
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Engagement in DNA repair mechanisms allows DDB2 to help maintain genomic stability. It forms a critical part of the DDB1-DDB2 complex which collaborates with other proteins in the initial damage recognition step of NER. This involvement ensures the repair of UV-induced damage and bulky DNA adducts preventing mutations that can cause harmful genetic alterations.
Pathways
The involvement of DDB2 is important within the nucleotide excision repair and transcription-coupled repair pathways. In these pathways DDB2 partners with proteins such as XPC and XPA facilitating the recognition and verification of DNA damage. These interactions ensure an accurate and efficient repair process protecting cells from potential genotoxic stress.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (18)
Recent publications for all applications. Explore the full list and refine your search
Journal of gastrointestinal oncology 13:3112-3122 PubMed36636074
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell transplantation 31:9636897221092778 PubMed35536165
2022
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 41:e110145 PubMed35349166
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:974 PubMed35190564
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological sciences 15:1460-1471 PubMed31337976
2019
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 72:888-901.e7 PubMed30344095
2018
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 9:259 PubMed29343685
2018
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 69:24-35.e5 PubMed29290612
2018
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 36:3372-3386 PubMed29018037
2017
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 291:10847-57 PubMed26994140
2016
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com